HomeACRS • NASDAQ
add
Aclaris Therapeutics Inc
Previous close
$2.36
Day range
$2.21 - $2.36
Year range
$1.05 - $5.17
Market cap
246.46M USD
Avg Volume
1.21M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 1.78M | -35.76% |
Operating expense | 5.39M | 13.34% |
Net income | -15.43M | -40.44% |
Net profit margin | -868.26 | -118.61% |
Earnings per share | -0.13 | 13.33% |
EBITDA | -16.88M | -33.84% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 99.81M | -10.16% |
Total assets | 189.15M | 17.43% |
Total liabilities | 57.41M | 110.68% |
Total equity | 131.74M | — |
Shares outstanding | 108.33M | — |
Price to book | 1.93 | — |
Return on assets | -21.83% | — |
Return on capital | -30.12% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -15.43M | -40.44% |
Cash from operations | -9.99M | 18.90% |
Cash from investing | 5.05M | 848.81% |
Cash from financing | -9.00K | 18.18% |
Net change in cash | -4.96M | 61.91% |
Free cash flow | -3.02M | 64.28% |
About
Founded
2012
Website
Employees
63
